Advertisement

Inhaled Nitric Oxide in Acute Respiratory Failure

  • L. Puybasset
  • J. J. Rouby
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1995)

Abstract

Gazeous nitric oxide (NO) and nitrogen dioxide (NO2) are well known atmospheric outdoor pollutants which toxicity was extensively studied in the seventies. In the eighties, inhaled NO was used in humans as an alternative to CO to measure the oxygen diffusing capacity of the lungs [1, 2]. In 1987, one of the endothelium-derived relaxing factors [3] was identified as NO [4]. It was then demonstrated that NO was continuously released by the endothelial cells after activation of the constitutive NO synthase in response to shear stress. Later, NO was found to be involved in a large number of physiological systems [5, 6] such as coagulation [7, 8], neuronal transmission and inflammation.

Keywords

Nitric Oxide Pulmonary Hypertension Pulmonary Arterial Hypertension Acute Respiratory Failure Adult Respiratory Distress Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Meyer M, Piiper J (1989) Nitric oxide (NO), a new test gas for study of alveolar capillary diffusion. Eur Respir J 2: 494–496PubMedGoogle Scholar
  2. 2.
    Moinard J, Guenard H (1990) Determination of lung capillary blood volume and membrane diffusing capacity in patients with COLD using the NO-CO method. Eur Respir J 3: 318–322PubMedGoogle Scholar
  3. 3.
    Furchgott RF, Zawadski JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376PubMedCrossRefGoogle Scholar
  4. 4.
    Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526PubMedCrossRefGoogle Scholar
  5. 5.
    Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109–142PubMedGoogle Scholar
  6. 6.
    Berdeaux A (1993) Nitric oxide: An ubiquitous messenger. Fundam Clin Pharmacol 7: 401–411PubMedCrossRefGoogle Scholar
  7. 7.
    Macdonald PS, Read MA, Dushing GJ (1988) Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Thromb Res 49: 437–449PubMedCrossRefGoogle Scholar
  8. 8.
    Alheid U, Frolich JC, Fosterman U (1987) Endothelial derived relaxing factor from human endothelial cells inhibits aggregation of human platelets. Thromb Res 47: 561–571PubMedCrossRefGoogle Scholar
  9. 9.
    Higenbottam T, Pepke-Zaba J, Scott J, Woolman P, Coutts C, Wallwork J (1988) Inhaled “endothelial derived-relaxing factor” (EDRF) in primary hypertension (PPH). Am Rev Respir Dis Suppl 137: A107 (Abst)Google Scholar
  10. 10.
    Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 338: 1173–1174PubMedCrossRefGoogle Scholar
  11. 11.
    Fratacci MD, Frostell CG, Chen TY, Wain JC, Robinson DR, Zapol WM (1991) Inhaled nitric oxide: A selective pulmonary vasodilator of heparin-Protamine vasoconstriction in sheep. Anesthesiology 75: 990–999PubMedCrossRefGoogle Scholar
  12. 12.
    Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038–2047PubMedGoogle Scholar
  13. 13.
    Pison U, Lopez FA, Heidelmeyer CF, Rossaint R, Falke K (1993) Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol 74: 1287–1292PubMedCrossRefGoogle Scholar
  14. 14.
    Roberts JD, Polaner DM, Lang P, Zapol WM (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 818–819PubMedCrossRefGoogle Scholar
  15. 15.
    Weitzberg E, Rudehill A, Alving K, Lundberg JM (1991) Nitric oxide inhalation selectively attenuates pulmonary hypertension and arterial hypoxia in porcine endotoxin shock. Acta Physiol Scand 143: 451–452PubMedCrossRefGoogle Scholar
  16. 16.
    Dyar O, Young JD, Xiong L, John S (1993) Dose-response relationship for inhaled nitric oxide in experimental pulmonary hypertension in sheep. Br Anaesth 71: 702–708CrossRefGoogle Scholar
  17. 17.
    Berger JI, Gibson RL, Redding GJ, Standaert TA, Clarke WR, Truog WE (1993) Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. Am Rev Respir Dis 147: 1080–1086PubMedGoogle Scholar
  18. 18.
    Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399–405PubMedCrossRefGoogle Scholar
  19. 19.
    Bigatello LM, Hurford WE, Kacmarek RM, Roberts JD, Zapol WM (1994) Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Anesthesiology 80: 761–770PubMedCrossRefGoogle Scholar
  20. 20.
    Puybasset L, Rouby JJ, Mourgeon E, et al (1994) Inhaled nitric oxide in acute respiratory failure: Dose-response curves. Intensive Care Med 20: 319–327PubMedCrossRefGoogle Scholar
  21. 21.
    Puybasset L, Stewart TE, Rouby JJ, et al (1994) Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with ARDS. Anesthesiology 80: 1254–1267PubMedCrossRefGoogle Scholar
  22. 22.
    Girard C, Lehot J, Pannetier J, Filley S, French P, Estanove S (1992) Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary hypertension. Anesthesiology 77: 880–883PubMedCrossRefGoogle Scholar
  23. 23.
    Rich FR, Murphy GD, Roos CM, Johns RA (1993) Inhaled nitric oxide: Selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 78: 1028–1035PubMedCrossRefGoogle Scholar
  24. 24.
    Adnot S, Kouyoumdjian C, Defouilloy C, et al (1993) Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 148: 310–316PubMedCrossRefGoogle Scholar
  25. 25.
    Moinard J, Manier G, Pillet O, Castaing Y (1994) Effect of inhaled nitric oxide on hemodynamics and VA/Q inequalities in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 149: 1482–1487PubMedGoogle Scholar
  26. 26.
    Stenqvist O, Kjelltoft B, Lundin S (1993) Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesthesiol Scand 37: 687–691PubMedCrossRefGoogle Scholar
  27. 27.
    Wessel DL, Adatia I, Thompson JE, Hickey PR (1994) Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 22: 930–938PubMedCrossRefGoogle Scholar
  28. 28.
    Mourgeon E, Puybasset L, Renaudin MH, et al (1994) Distribution of NO concentrations during 2 methods of NO inhalation. Br J Anaest 72 (Suppl 1): A18 (Abst)Google Scholar
  29. 29.
    Capeliier G, Belle F, Fouche R, Maheu MF, Barale F (1993) Intérêt d’une régulation de l’administration de monoxyde d’azote. Réan Soins Intens Méd Urg 2: 706 (Abst)Google Scholar
  30. 30.
    Germann P, Balassa A, Poschl G, et al (1994) A new system for differentiated application and continous measurements of nitric oxide and nitrogen dioxide. Anesthesiology 81 (Suppl 3 A): A 556 (Abst)Google Scholar
  31. 31.
    Zapol WM, Rimar S, Gillis N, Bosken CH (1994) Nitric oxide and the lung. Am J Respir Crit Care Med 149: 1375–1380PubMedGoogle Scholar
  32. 32.
    Bauer MA, Utell MJ, Morrow PE, Speers DM, Gibb FR (1986) Inhalation of 0,30 ppm nitrogen dioxide potentiates exercice-induced bronchospasm in asthmatics. Am Rev Respir Dis 134: 1203–1208PubMedGoogle Scholar
  33. 33.
    Sandström T, Stjernberg N, Eklund A, et al (1991) Inflammatory cell response in bron- choalveolar lavage fluid after nitrogen dioxide exposure of healthy subjects: A dose-response study. Eur Respir J 3: 332–339Google Scholar
  34. 34.
    Wennmaln A, Benthin G, Edlund A, et al (1993) Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 73: 1121–1127Google Scholar
  35. 35.
    Law-Koune JD, Roche S, Mourgeon E, et al (1994) Acute toxicity of inhaled NO in ARDS. Anesthesiology 81: A263 (Abst)CrossRefGoogle Scholar
  36. 36.
    Motsch J, Bach A, Böher H, Gagel K, Martin E (1994) Reduction of nitric dioxide formation during nitric oxide inhalation Anesthesiology 81 (Suppl 3 A): A1268 (Abst)Google Scholar
  37. 37.
    Isomura K, Chikahira M, Terashini K, Hamada K (1984) Induction of mutations and chromosome aberrations in lung cells following in vivo exposures to nitrogen oxides. Mutation Res 136: 119–125PubMedCrossRefGoogle Scholar
  38. 38.
    Arroyo PL, Hatch-Pigott V, Mower HF, Cooney RV (1992) Mutagenecity of nitric oxide and its inhibition by antioxidants. Mutation Res 281: 193–202PubMedCrossRefGoogle Scholar
  39. 39.
    Nguyen T, Brunson D, Crospi CL, Penman BW, Wishnok JS, Tannenbaum SR (1992) DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 89: 3030–3034PubMedCrossRefGoogle Scholar
  40. 40.
    Wink DA, Kasprzak KS, Maragos CM, et al (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254: 1001–1003PubMedCrossRefGoogle Scholar
  41. 41.
    Beckman JS, Beckman TW, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620–1624PubMedCrossRefGoogle Scholar
  42. 42.
    Haddad LY, Crow JP, Yaozu Y, Beckman J, Matalon S (1994) Concurrent generation of nitric oxide and superoxide damages surfactant protein A (SP-A). Am J Respir Crit Care Med 149: A549 (Abst)Google Scholar
  43. 43.
    Greenbaum R, Bay J, Hargreaves MD, et al (1967) Effects of higher oxides of nitrogen in the anaesthetized dog. Br J Anaesth 39: 393–404PubMedCrossRefGoogle Scholar
  44. 44.
    Oda H, Nogami H, Kusumotos S, Nakajima T, Kurata A, Imai K (1976) Long-term exposure to nitric oxide in mice. J Jpn Soc Air Pollut 11: 150–160Google Scholar
  45. 45.
    Oda H, Nogami H, Kusumoto S, Nakajima T, Kurata A (1980) Lifetime exposure to 2.4 ppm nitric oxide in mice. Env Res 22: 254–263CrossRefGoogle Scholar
  46. 46.
    Azoulay E, Soler P, Blayo MC, Basset F (1977) Nitric oxide effects on lung structure and blood oxygen affinity in rats. Bull Europ Physiopath Respir 13: 629–644Google Scholar
  47. 47.
    Foubert L, Fleming B, Latimer R, et al (1992) Safety guidelines for use of nitric oxide. Lancet 39: 1615–1616CrossRefGoogle Scholar
  48. 48.
    Man SFP, Williams DJ, Amy GC, Man GCW, Lien DC (1990) Sequential changes in canine pulmonary epithelial and endothelial cell functions after nitrogen dioxide. Am Rev Respir Dis 142: 199–205PubMedGoogle Scholar
  49. 49.
    Ranga V, Kleinerman J, Ip MPC, Collins AM (1980) The effect of nitrogen dioxide on tracheal uptake and transport of horseradish peroxidase in the guinea pig. Am Rev Respir Dis 122: 483–490PubMedGoogle Scholar
  50. 50.
    Guth DJ, Mavis RD (1985) Biochemical assessment of acute nitrogen dioxide toxicity in rat lung. Toxicol Appl Pharmacol 81: 128–138PubMedCrossRefGoogle Scholar
  51. 51.
    Stavert DM, Lehnert BE (1990) Nitrogen oxide and nitrogen dioxide as inducers of acute pulmonary injury when inhaled at relatively high concentrations for brief periods. Inhal Toxicol 2: 53–57CrossRefGoogle Scholar
  52. 52.
    Ben-Jebria A, Marthan R, Savineau JP (1992) Effect of in vitro nitrogen dioxide exposure on human bronchial smooth muscle response. Am Rev Respir Dis 46: 378–382Google Scholar
  53. 53.
    Frampton MW, Morrow PE, Cox C, Gibb FR, Speers DM, Utell MJ (1991) Effects of nitrogen dioxide exposure on pulmonary function and airway reactivity in normal humans. Am Rev Respir Dis 143: 522–527PubMedGoogle Scholar
  54. 54.
    Hazucha MJ, Founsbee LJ, Sead E, Bromberg PA (1994) Lung function response of healthy women after sequential exposures to NO2 and O3. Am J Respir Crit Care Med 150: 642–647PubMedGoogle Scholar
  55. 55.
    Rose RM, Fuglestad JM, Skornik WA, et al (1988) The pathophysiology of enhanced susceptibility to murine cytomegalovirus respiratory infection during short-term exposure to 5 ppm nitrogen dioxide. Am Rev Respir Dis 137: 912–917PubMedGoogle Scholar
  56. 56.
    Mustafa MG, Tierney DF (1978) Biochemical and metabolic changes in the lung with oxygen, ozone, and nitrogen dioxide toxicity. Am Rev Respir Dis 18: 1061–1088Google Scholar
  57. 57.
    Radermacher P, Santak B, Wüst HJ, Tarnow J, Falke KJ (1990) Prostacyclin for the treatment of pulmonary hypertension in patients with acute respiratory distress syndrome: Effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 72: 238–244PubMedCrossRefGoogle Scholar
  58. 58.
    Radermacher P, Santak B, Becker H, Falke KJ (1989) Prostaglandine E1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology 70: 601–606PubMedCrossRefGoogle Scholar
  59. 59.
    Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA (1994) Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89: 2035–2040PubMedGoogle Scholar
  60. 60.
    Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM (1993) Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78: 427–435PubMedCrossRefGoogle Scholar
  61. 61.
    Puybasset L, Rouby JJ, Mourgeon E, et al (1995) Factors influencing respiratory effects of inhaled NO in acute respiratory failure. Am J Respir Crit Care Med (in press)Google Scholar
  62. 62.
    Langleben D, Demarchie M, Laporta D, Spanier AH, Schlesinger RD, Stewart DJ (1993) Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. Am Rev Respir Dis 48: 1646–1650CrossRefGoogle Scholar
  63. 63.
    Zapol WM, Snider MT, Rie MA, Quinn DA, Frikker M (1985) Pulmonary circulation during adult respiratory distress syndrome. In: Zapol WM, Falke KJ (eds) Acute respiratory failure. Dekker, New York, pp 209–226Google Scholar
  64. 64.
    McGregor M, Sniderman A (1985) On pulmonary vascular resistance: The need for more precise definition. Am J Cardiol 55: 217–227PubMedCrossRefGoogle Scholar
  65. 65.
    Bshouty Z, Younes M (1990) Distensibility and pressure flow relationships of the pulmonary circulation. II. Multibranched model. J Appl Physiol 68: 1514–1527PubMedGoogle Scholar
  66. 66.
    Gattinoni L, Pesenti A, Avalli L, Rossi F, Bombino M (1987) Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. Am Rev Respir Dis 136: 730–736PubMedCrossRefGoogle Scholar
  67. 67.
    Bocchi EA, Bacal F, Costa Auter JO, De Carvalho C, Bellotti G, Pileggi F (1994) Inhaled nitric oxide leading to pulmonary, edema in stable severe heart failure. Am J Cardiol 74: 70–72PubMedCrossRefGoogle Scholar
  68. 68.
    Kieler-Jensen N, Ricksten SE, Stengvist O, et al (1994) Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 13: 366–375PubMedGoogle Scholar
  69. 69.
    Jones R, Langleben D, Reid LM (1991) Patterns and mechanisms of remodeling of the pulmonary circulation in acute and subacute lung injury. In: Said SI (ed) The pulmonary circulation and acute lung injury. Futura Publishing Company, Mount Kisko, NY, pp 179–242Google Scholar
  70. 70.
    Lindeborg DM, Pearl RG (1993) Inhaled nitric oxide and the longitudinal distribution of pulmonary vascular resistance. Am Rev Respir Dis 147: A225 (Abst)Google Scholar
  71. 71.
    Stewart TE, Rouby JJ, Puybasset L, Mourgeon E, Descouls AM, Viars P (1994) Inhaled NO reduces alveolar dead space in patients with ARDS and pulmonary hypertension. Am J Respir Crit Care Med 149: A424 (Abst)Google Scholar
  72. 72.
    Dupuy PM, Shore SA, Drazen JM, Frostell C, Hill WA, Zapol WM (1992) Bronchodilator action of inhaled nitric oxyde in guinea pigs. J Clin Invest 90: 421–428PubMedCrossRefGoogle Scholar
  73. 73.
    Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774–1777PubMedCrossRefGoogle Scholar
  74. 74.
    Högman M, Frostell CG, Arnberg H, Hedenstierna G (1993) Bleeding time prolongation and NO inhalation. Lancet 341: 1664–1665PubMedCrossRefGoogle Scholar
  75. 75.
    Niu XF, Smith W, Kubes P (1994) Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 74: 1133–1140PubMedGoogle Scholar
  76. 76.
    Kavanach BP, Mouchawar A, Goldsmith J, Pearl RG (1994) Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J Appl Physiol 76: 1324–1329Google Scholar
  77. 77.
    Rimar S, Gillis CN (1992) Pulmonary vasodilation by inhaled nitric oxide after endothelial injury. J Appl Physiol 73: 2179–2183PubMedGoogle Scholar
  78. 78.
    White CW, Nguyen DH, Tuder R (1994) Nitric oxide modulation of hyperoxic injury. Am J Respir Crit Care Med 149: A548 (Abst)Google Scholar
  79. 79.
    Berisha H, Pakbaz H, Absood A, Said SI (1994) Excess nitric oxide (NO) production in acute lung injury: Role of constitutive vs inducible NO synthase. Am J Respir Crit Care Med 149: A552 (Abst)Google Scholar
  80. 80.
    Högman M, Frostell CG, Arnberg H, Hedenstierna G (1993) Inhalation of nitric oxide modulates metacholine-induced bronchoconstriction in the rabbit. Eur Respir J 6: 177–180PubMedGoogle Scholar
  81. 81.
    Puybasset L, Mourgeon E, Segal E, Bodin L, Rouby JJ, Viars P (1993) Effects of inhaled nitric oxide on respiratory resistance in patients with ARDS. Anesthesiology 79: A299 (Abst)CrossRefGoogle Scholar
  82. 82.
    Högman M, Frostell CG, Hedenström H, Hedenstierna G (1993) Inhalation of nitric oxide modulates adult bronchial tone. Am Rev Respir Dis 148: 1474–1478PubMedCrossRefGoogle Scholar
  83. 83.
    Kilbourn RG, Jubran SS, Griffith OW, Levi R, Adams J, Lodato RF (1990) Reversal of endotoxin mediated shock by NG-Methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172: 1132–1138PubMedCrossRefGoogle Scholar
  84. 84.
    Kilbourn RG, Gross SS, Jubran SS, et al (1990) NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87: 3629–3632PubMedCrossRefGoogle Scholar
  85. 85.
    Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC (1990) Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 259 (Heart Circ Physiol 28): H1038–H1043PubMedGoogle Scholar
  86. 86.
    Mourgeon E, Roche S, Lu Q, et al (1994) NO inhalé dans le SDRA: courbes dose-réponse en présence ou en l’absence de choc septique. Ann Fr Anesth Réanim 13 (Suppl): R252 (Abst)Google Scholar
  87. 87.
    Gerlach H, Rossaint R, Pappert D, Falke KJ (1993) Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23: 499–502PubMedCrossRefGoogle Scholar
  88. 88.
    Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ (1993) Long-term inhalation with evaluated low doses of nitric oxide for selective improvement in oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 19: 443–449PubMedCrossRefGoogle Scholar
  89. 89.
    Journois D, Pouard P, Mauriat P, Malhère T, Vouhé P, Safran D (1994) Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital defects. J Thorac CardioVasc Surg 107: 1129–1135PubMedGoogle Scholar
  90. 90.
    Sellden H, Winberg P, Gustafsson LE, Lundell BO, Book K, Frosteil CG (1993) Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2 kg infant. Anesthesiology 78: 577–580PubMedCrossRefGoogle Scholar
  91. 91.
    Tiner NN, Etches RC, Kamstra B, Tierney AJ, Peliowski A, Ryan A (1994) Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose-response. J Pediatr 124: 302–308CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • L. Puybasset
  • J. J. Rouby

There are no affiliations available

Personalised recommendations